Essai clinique
Récupéré
Publication
clinicaltrials.gov
Quadrant Biosciences Inc., University of California, Irvine, Holland Bloorview Kids Rehabilitation Hospital, Children's Hospital of Philadelphia, MetroHealth Medical Center, University of Rochester, Nationwide Children's Hospital, Children's Hospital Medical Center, Cincinnati, et al.
(2022).
Validation of a Salivary miRNA Diagnostic Test for ASD.
ClinicalTrials.gov.
Quadrant Biosciences Inc..
- Date de publication
-
16/03/2022
- Identifiant
-
NCT05418023
- Auteurs
-
Quadrant Biosciences Inc.,
University of California, Irvine,
Holland Bloorview Kids Rehabilitation Hospital,
Children's Hospital of Philadelphia,
MetroHealth Medical Center,
University of Rochester,
Nationwide Children's Hospital,
Children's Hospital Medical Center, Cincinnati,
University of Pittsburgh,
University of Massachusetts, Worcester,
Children's Hospital Los Angeles,
Prisma Health-Upstate,
University of Virginia,
State University of New York - Upstate Medical University,
Rush University,
Seattle Children's Hospital,
Drexel University,
Emory University
- Source
- ClinicalTrials.gov
- Type de référence
- clinical_trial
- Éditeur
- Quadrant Biosciences Inc.
- Source de métadonnées
- clinicaltrials.gov
Résumé
This study involves sample collection to identify biomarkers relating to Autism Spectrum Disorder(ASD) in the saliva of children who are between the ages of 18 months to 6 years and 11 months. Participants will at each timepoint have a non-invasive saliva swab collected and complete a brief demographic and medical history questionnaire as well. Children in the pediatric/provider setting who will receive a referral for an ASD diagnosis because they were determined to have a suspicion of developing ASD will be enrolled in the study. Children will also be enrolled in the specialist evaluation setting where they will receive a DSM-5 diagnosis. A subset of both enrollment cohorts will also be followed up with at a third time point in which their diagnosis will be confirmed, and information about any ongoing treatment will be gathered.